FI922612A - Nya proteiner med oncostatin m aktivi- tet och foerfarande foer deras framstaellning. - Google Patents

Nya proteiner med oncostatin m aktivi- tet och foerfarande foer deras framstaellning. Download PDF

Info

Publication number
FI922612A
FI922612A FI922612A FI922612A FI922612A FI 922612 A FI922612 A FI 922612A FI 922612 A FI922612 A FI 922612A FI 922612 A FI922612 A FI 922612A FI 922612 A FI922612 A FI 922612A
Authority
FI
Finland
Prior art keywords
oncostatin
mutants
oncostat
proteiner
faring
Prior art date
Application number
FI922612A
Other languages
English (en)
Other versions
FI104424B (fi
FI922612A0 (fi
Inventor
Peter S Linsley
Jeffrey C Kallestad
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of FI922612A publication Critical patent/FI922612A/fi
Publication of FI922612A0 publication Critical patent/FI922612A0/fi
Application granted granted Critical
Publication of FI104424B publication Critical patent/FI104424B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
FI922612A 1989-12-08 1992-06-05 Menetelmä onkostatiini M -mutantin valmistamiseksi FI104424B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US44775989A 1989-12-08 1989-12-08
US44775989 1989-12-08
US62386790A 1990-12-03 1990-12-03
US62386790 1990-12-03
PCT/US1990/007227 WO1991009057A1 (en) 1989-12-08 1990-12-07 Novel proteins with oncostatin m activity and process for their preparation
US9007227 1990-12-07

Publications (3)

Publication Number Publication Date
FI922612A true FI922612A (fi) 1992-06-05
FI922612A0 FI922612A0 (fi) 1992-06-05
FI104424B FI104424B (fi) 2000-01-31

Family

ID=27035080

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922612A FI104424B (fi) 1989-12-08 1992-06-05 Menetelmä onkostatiini M -mutantin valmistamiseksi

Country Status (17)

Country Link
EP (1) EP0504291B1 (fi)
JP (1) JPH05504134A (fi)
KR (1) KR920703636A (fi)
CN (1) CN1055389A (fi)
AT (1) ATE168117T1 (fi)
AU (1) AU651330B2 (fi)
CA (1) CA2070171A1 (fi)
DE (1) DE69032471T2 (fi)
DK (1) DK0504291T3 (fi)
ES (1) ES2120958T3 (fi)
FI (1) FI104424B (fi)
GR (1) GR3027654T3 (fi)
IL (1) IL96593A0 (fi)
NO (1) NO301769B1 (fi)
NZ (1) NZ236382A (fi)
PT (1) PT96134B (fi)
WO (1) WO1991009057A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
CA2178256A1 (en) * 1995-06-06 1996-12-07 Christopher H. Clegg Oncostatin m induced hematopoiesis
GB9806530D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Inflammatory mediator
US20120308517A1 (en) 2010-02-09 2012-12-06 Digna Biotech, S.L. Compositions for the treatment of infectious and tumoural diseases

Also Published As

Publication number Publication date
ES2120958T3 (es) 1998-11-16
CA2070171A1 (en) 1991-06-09
DE69032471D1 (de) 1998-08-13
AU651330B2 (en) 1994-07-21
DE69032471T2 (de) 1999-03-04
NO922202L (no) 1992-06-04
DK0504291T3 (da) 1998-11-30
EP0504291A4 (en) 1992-10-28
PT96134B (pt) 1998-04-30
IL96593A0 (en) 1991-09-16
KR920703636A (ko) 1992-12-18
EP0504291B1 (en) 1998-07-08
FI104424B (fi) 2000-01-31
NO301769B1 (no) 1997-12-08
WO1991009057A1 (en) 1991-06-27
CN1055389A (zh) 1991-10-16
FI922612A0 (fi) 1992-06-05
EP0504291A1 (en) 1992-09-23
GR3027654T3 (en) 1998-11-30
NZ236382A (en) 1992-08-26
ATE168117T1 (de) 1998-07-15
JPH05504134A (ja) 1993-07-01
NO922202D0 (no) 1992-06-04
PT96134A (pt) 1991-09-30
AU7036191A (en) 1991-07-18

Similar Documents

Publication Publication Date Title
GB8912330D0 (en) Live vaccines
DE3876401D1 (de) N-terminale fragmente von menschlichem serumalbumin.
DE69131699D1 (de) Verändertes menschliches iL-6
ES2179833T3 (es) Procedimiento de preparacion de material ceramico para implante en particular material ceramico para implante que contiene hidroxiapatita.
FI864293A (fi) Neovaskularisationsinhibitorer och deras framstaellnings- och anvaendningsfoerfaranden.
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
ES2055611T3 (es) Pdgf resistente a proteasas y metodos de uso.
FI922612A0 (fi) Nya proteiner med oncostatin m aktivi- tet och foerfarande foer deras framstaellning.
ATE112320T1 (de) Sekretormutante von escherichia coli.
DK0757994T3 (da) TCF-mutanter
DE69528473D1 (de) Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen
ITRM920809A1 (it) Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
ES2052883T3 (es) Cultivo de celulas de riñon de cerdo y su uso en la produccion de vacunas.
DE58909261D1 (de) Ancrod-proteine, ihre herstellung und verwendung.
NO884054D0 (no) Nytt pentapeptid og fremgangsmaate for fremstilling derav.
Yasnii The Fatigue Crack Growth Rate Data Base
PL285546A1 (en) Biological culture medium for cell cultures and method of culturing human keratocytes as well as proteinous concentrate